HSANZ has been working hard in collaboration with RCPAQAP  to create CPD opportunities for Members.  These will be rolled out during the next year and below, we invite you to participate in two Haematology Case Studies for CPD.

The case studies are open to Haematologists and registrars in Australia and New Zealand. Scientists with relevant experience may also submit responses. Your answers will not be graded, and a discussion report will be emailed after your submission for self-assessment.

Each case study has three sections, completion of all three sections will award you 30 minutes towards RCPA CPD.  You can access the first section of each case below; you can navigate to the subsequent sections using the links at the end of sections 1 and 2.

Closing date: 5pm AEDT, 31 January, 2022

Case Study 1 relates to abnormal haematology and biochemistry results, morphology, as well as flow cytometry and conventional Cytogenetics.
Case study 1, Section 1 of 3

Case Study 2 will explore the investigation of anaemia in a young woman.
Case Study 2, Section 1 of 3

ACORD22 Protocol Development Workshop 

The Medical Oncology Group of Australia invites applications from early-career clinical cancer researchers from all oncology subspecialties based in the Asia Pacific region for our third one-week online ACORD22 Protocol Development Workshop. 

ACORD’s global focus, task-oriented format, collaborative approach, and one-on-one guidance, mentoring and networking with world-renowned faculty, make it a unique career-enhancing opportunity.

Early-career clinical cancer researchers, from all specialties and disciplines, are encouraged to submit their ideas for selection

25 – 30 Sep | Online

Submission Deadline: 31 March 2022

HSANZ  and ALLG Welcome the House of Representatives’ Standing Committee Report tabled in Parliament 25 November 2021

Overview:

The ALLG and HSANZ welcomes the Report tabled in Parliament 25/11/21 on ‘The New Frontier - Delivering better health for all Australians: Inquiry into approval processes for new drugs and novel medical technologies in Australia’, by the House of Representatives Standing Committee on Health, Aged Care and Sport.

Medical innovation has grown exponentially in recent years. The approval processes for new medicines are very complex, and this report discusses different ways to streamline them to provide better and faster patient access to treatments; without compromising on patient safety, efficacy or cost effectiveness.

The Committee’s Report details 31 recommendations which aim to help government improve and reform the regulatory and reimbursement system; and helps pave the way for the improvements needed to provide Australians with the best possible health care now and into the future.

To read the full ALLG and HSANZ statement, click here

This article, co-authored by Steven Lane in The Hematologist provides a summary of the recent literature regarding COVID Vaccination responses in patients with blood cancers. This might be of use when providing information to patients about their options to prevent COVID19 infection.

Click here for the link

Dear Colleagues, re: The ATAGI recommendation for COVID Vaccination in immunocompromised patients

This is an important recommendation from ATAGI and is relevant to many patients with haematological disorders who may have reduced response to standard COVID vaccination regimens. 
Steven Lane, President HSANZ

Click here for document

HSANZ Council was pleased to award the Albert Baikie Medal and Award for 2021 to Salvatore (Sam) Fiorenza at Blood2021.  Congratulations Sam

Blood2021 on-demand Registration HSANZ sponsorships

With the completion of the live component of the Virtual Blood 2021, HSANZ would like to extend our appreciation to all members who contributed, participated and attended this meeting. The on-demand viewing for all presentations during Blood 2021 will be available for 6 months, as above.

 We do realise that a proportion of our haematology constituents were not able to attend live, and therefore announce that HSANZ is offering on-demand registration sponsorship to a select number (maximum 10) of Haematology Advanced Trainees across all states who meet the following eligibility criteria:

 1.         You must be an active trainee member of HSANZ or have an HSANZ trainee membership submission pending approval to qualify (you must have submitted a signed application form and CV)

Applications close: 31 October 2021.

Please apply by emailing documentation to email

The Centre for Blood Transplant and Cell Therapies (CBTCT) brings together the largest allogeneic stem cell transplant units in Australia with a focus on identifying transplant and cell therapy strategies to reduce graft versus host disease and improve patient and disease outcomes after transplant. In this webinar series, speakers will review major topics in stem cell transplantation and cell therapy, highlighting how key advances are addressing the current challenges in stem cell transplantation. The tenth webinar in this series features Professor Mohamad Mohty, who is the head of the Haematology and Cellular Therapy Department at the Saint-Antoine Hospital and the head of the translation research team at the Saint-Antoine Research Centre in Paris. He is the past president of the European Society for Blood and Marrow Transplantation (EBMT) and the current chairman of the Acute Leukaemia Working Party of the EBMT. He has published over 800 peer-reviewed articles in the field of stem cell transplantation, leukaemia and myeloma. In this webinar, Prof Mohty will be outlining the role of maintenance therapeutics following allogeneic HSCT for acute leukaemia.

Speaker:

Professor Mohamad Mohty – Saint-Antoine Hospital and Sorbonne University

When: Monday 11 October 2021, 5pm AEDT

For  more information click here

Link to webinar:

https://uni-sydney.zoom.us/j/92998014030

Link to CBTCT website for all webinar recordings:

https://bloodcelltherapy.org.au/

The Baker Department of Cardiometabolic Health is hosting a VITT webinar between 4-5:20pm (AEST ) this Thursday, 9 Sept. Speakers include Andreas Greinacher and James McFadyen, with Kanta Subbarao, Huyen Tran and Liz Gardiner joining a panel discussion. Registration is free here

For more information click here

NOTICE OF ANNUAL GENERAL METING 2021

NOTICE IS HEREBY GIVEN THAT THE ANNUAL GENERAL METING OF THE HAEMATOLOGY SOCIETY OF AUSTRALIA AND NEW ZEALAND WILL BE HELD ON WEDNESDAY 22 SEPTEMBER VIA ZOOM

COMMENCING AT 4.00PM AEST

FINANCIAL MEMBERS ONLY CAN VOTE

MEMBERS CAN REGISTER HERE